Latest Articles & Resources FEATURED FDA’s GLP-1 Crackdown: Regulators Are Turning Up the Heat on Manufacturing Quality Read More » FDA’s GLP-1 Crackdown: Regulators Are Turning Up the Heat on Manufacturing Quality Read More » LATEST NEWS + INTERVIEWS Therna Biosciences Collaborates with Charles River on Personalized RNA Therapeutics Upperton Files MHRA Approval for 7,000 sq. ft Sterile CDMO Manufacturing Facility Matrix Pharma Corp Inaugurates Oncology Manufacturing Facility in Vizag Lifecore Biomedical Signs Development Agreement with Indomo for DT-001 Acne Therapy Frontage Laboratories Completes Acquisition of Teddy Lab Altruist Biologics Launches Altru-CON™ Platform Enabling Biologics Concentrations up to 200 mg/mL Minaris Launches AgentSCREEN™ NGS Platform for Adventitious Virus Detection in Biologics and Cell Therapies Biotech CMC: Scaling Gene Therapy for Longevity Forma Life Sciences Launches U.S.-Based Oral Solid Dosage CDMO Platform Codis Expands UK Manufacturing with Commercial-Scale PSD-4 Spray Dryer at Haverhill Facility Codexis Signs Agreement to Manufacture 50 Grams of siRNA Using ECO Synthesis Platform CordenPharma Colorado Leases 64,000 Square Feet at BioMed Realty’s Flatiron Park in Boulder FUJIFILM Biotechnologies Unveils ShunzymeX Technology to Simplify Purification of Complex Biologics Forge Biologics to Support SamPro-2 Gene Therapy Manufacturing for Progeria Program BioDuro Forms API Manufacturing Joint Venture With Cenra in Taiwan ESTEVE CDMO Begins $15.5 Million Expansion at Morton Grove API Site How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains Most CMC Failures Are Visible Months Before They Happen Why FDA’s CRL wave isn’t a CMC crisis — and what biotechs should do instead Scinai Immunotherapeutics Seeks €12 Million Grant to Advance PC111 for Autoimmune Diseases The European Biotech Act, Explained PODCAST INTERVIEWS How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO
Minaris Launches AgentSCREEN™ NGS Platform for Adventitious Virus Detection in Biologics and Cell Therapies
Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy
How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO
